1. Experience with viral contamination in cell culture;Garnick;Dev Biol Stand,1996
2. Impact of cell culture process changes on endogenous retrovirus expression;Brorson;Biotechnol Bioeng,2002
3. FDA, Guidance for industry - Q5A Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin, (1999).
4. Preparation of virus spikes used for virus clearance studies;Parenteral Drug Association,2010
5. Integrated viral clearance strategies-reflecting on the present, projecting to the future;Roush;Curr Opin Biotechnol,2018